ALKBH5 acts as a modification switch of lncRNA SOX2OT and participates in the lncRNA-mediated competitive endogenous RNA model to enhance the molecular stability and exploit the function of SOX2OT, thus affecting progression and drug resistance in glioma [22]. The gene discussed is ALKBH5; the disease is central nervous system cancer.